These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32032576)
1. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway. Yamada N; Matsushima-Nishiwaki R; Kozawa O Arch Biochem Biophys; 2020 Mar; 682():108296. PubMed ID: 32032576 [TBL] [Abstract][Full Text] [Related]
2. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301 [TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway. Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666 [TBL] [Abstract][Full Text] [Related]
4. Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity. Matsushima-Nishiwaki R; Kamoi S; Kozawa O Cell Biochem Funct; 2023 Oct; 41(7):814-822. PubMed ID: 37814477 [TBL] [Abstract][Full Text] [Related]
5. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway. Yamada N; Matsushima-Nishiwaki R; Kobayashi K; Tachi J; Kozawa O Arch Biochem Biophys; 2021 May; 703():108851. PubMed ID: 33771507 [TBL] [Abstract][Full Text] [Related]
6. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways. Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1. Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706 [TBL] [Abstract][Full Text] [Related]
19. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047 [TBL] [Abstract][Full Text] [Related]